Pages

• Checkout
• Transaction Results
• Your Account
• Adjuvant store
• Home
• Contact us
• About Isconova
  • History
  • Company Milestones
  • Senior Management Team
  • Board of Directors
  • Investor Relations
  • Careers
• Applications
  • Immunology research
  • Vaccine development
    • Vaccines on the market
  • Antibody production
  • Human applications
  • Veterinary application
    • Companion animals
    • Livestock animals
• ISCOM Technology
  • Advantages of ISCOMs
  • Adjuvants in general
  • Search PubMed
• Business collaborations
  • Collaboration guidelines
• Privacy policy
• Trademarks

Posts

• Category: News & Press
  • Great expectations—Isconova to receive the 2010 Bona Postulata Prize February 12th, 2010
  • Isconova AB appoints Lena Söderström as new CEO August 24th, 2009
  • Isconova reaches milestone in influenza vaccine collaboration July 20th, 2009
  • Study shows that Isconova´s Matrix-M is an excellent pandemic influenza vaccine candidate November 23rd, 2009
  • Category: Corporate news
    • Isconova Announces New Board Member December 24th, 2008
    • Isconova announces New board of Directors (in Swedish only) September 26th, 2007
    • Isconova secures 30 million Swedish kronor growth financing August 27th, 2008
    • Isconova signs distribution agreement with Biogenuix Medsystems Pvt. Ltd. November 1st, 2008
    • Isconova signs distribution agreement with Funakoshi Co, Ltd. April 15th, 2006
    • Meet Isconova at Biopartnering Europe Oct 13-14 in London August 28th, 2008
  • Category: Press releases
    • Great expectations—Isconova to receive the 2010 Bona Postulata Prize February 12th, 2010
    • Isconova AB appoints Lena Söderström as new CEO August 24th, 2009
    • Isconova licensing partner launches ISCOM vaccine December 19th, 2006
    • Isconova reaches milestone in influenza vaccine collaboration July 20th, 2009
    • Study shows that Isconova´s Matrix-M is an excellent pandemic influenza vaccine candidate November 23rd, 2009
    • Two cornerstone patent applications granted in Europe January 22nd, 2009
• Category: PubMed highlights
  • Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: Impact of distinct additional adjuvants July 4th, 2008
  • Immunodominant Francisella tularensis antigens identified using proteome microarray. Crown Copyright 2007 Dstl. June 7th, 2007
  • Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine May 18th, 2006
  • Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. October 18th, 2005